Randomised controlled trials of antipsychotics for people with autism spectrum disorder: a systematic review and a meta-analysis.

There is some evidence for risperidone and preliminary evidence for aripiprazole to significantly improve scores on some outcome measures among children with autism but not adults or for any other antipsychotics. There is a definite increased risk of antipsychotic-related different adverse effects.